Picture of Poxel SA logo

POXEL — Poxel SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Poxel Finalized Recruitment In Phase II Study Of PXL065

Sept 21 (Reuters) - Poxel SA  POXEL.PA :
    * FINALIZED THE RECRUITMENT OF PATIENTS WITH NON-CIRRHOTIC
NASH
CONFIRMED BY BIOPSY IN THE PHASE II STUDY OF PXL065 (DESTINY-1)
    * FIRST RESULTS OF THE PHASE II STUDY OF 123 PATIENTS WITH
NON-CIRRHOTIC NASH CONFIRMED BY BIOPSY ARE EXPECTED IN Q3 OF
2022

Source text for Eikon:  ID:nBwbKDRqPa 
Further company coverage:  POXEL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Poxel SA

See all news